Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer
| Image |  |
|---|---|
| Description | scientific article published on February 2015 |
| Author/s |
author: Datiles MB 3rd |
| Publication date | February 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |